Correlation Between Biotechnology Fund and Columbia Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Columbia Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Columbia Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Columbia Global Technology, you can compare the effects of market volatilities on Biotechnology Fund and Columbia Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Columbia Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Columbia Global.

Diversification Opportunities for Biotechnology Fund and Columbia Global

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between BIOTECHNOLOGY and Columbia is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Columbia Global Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Columbia Global Tech and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Columbia Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Columbia Global Tech has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Columbia Global go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Columbia Global

Assuming the 90 days horizon Biotechnology Fund is expected to generate 2.16 times less return on investment than Columbia Global. In addition to that, Biotechnology Fund is 1.19 times more volatile than Columbia Global Technology. It trades about 0.01 of its total potential returns per unit of risk. Columbia Global Technology is currently generating about 0.04 per unit of volatility. If you would invest  8,979  in Columbia Global Technology on August 31, 2024 and sell it today you would earn a total of  75.00  from holding Columbia Global Technology or generate 0.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Columbia Global Technology

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Columbia Global Tech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Columbia Global Technology are ranked lower than 10 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Columbia Global may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Biotechnology Fund and Columbia Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Columbia Global

The main advantage of trading using opposite Biotechnology Fund and Columbia Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Columbia Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Columbia Global will offset losses from the drop in Columbia Global's long position.
The idea behind Biotechnology Fund Class and Columbia Global Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio